Market revenue in 2023 | USD 851.3 million |
Market revenue in 2030 | USD 4,961.6 million |
Growth rate | 28.6% (CAGR from 2024 to 2030) |
Largest segment | Oncology |
Fastest growing segment | Infectious Disease |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Oncology, Neurodegenerative Diseases, Cardiovascular Disease, Metabolic Diseases, Infectious Disease, Other |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to artificial intelligence in drug discovery market will help companies and investors design strategic landscapes.
Oncology was the largest segment with a revenue share of 22.44% in 2023. Horizon Databook has segmented the North America artificial intelligence in drug discovery market based on oncology, neurodegenerative diseases, cardiovascular disease, metabolic diseases, infectious disease, other covering the revenue growth of each sub-segment from 2018 to 2030.
Strong economic growth and presence of well-equipped hospitals, research centers, universities, & medical device manufacturers are factors boosting the development of new products in this region.
In addition, increasing need for managing & controlling overall costs & time associated with discovery & development of drugs, increasing cross-industry collaborations & partnerships, surge in the adoption of cloud-based services & applications, and impending patent expiry of blockbuster drugs are expected to further drive the market in North America.
For instance, in May 2018, Intel announced its collaboration with Novartis for using deep neural networks to increase high-content screening to support early drug discovery. The current COVID-19 pandemic has further created a sense of urgency, which in turn, is improving the demand for AI in drug discovery.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America artificial intelligence in drug discovery market , including forecasts for subscribers. This continent databook contains high-level insights into North America artificial intelligence in drug discovery market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account